ApoB test cost (2026): prices in Europe and the US

How much does an ApoB test cost in Europe?

Cheapest ApoB in Europe: €8.23 in Bulgaria; most expensive €200 in Germany – 24.3× for the same marker. Lowest price per country, cheapest first. Full lists: European price index.

Dark = you can order it yourself · Grey ⓘ = check before ordering (tap for why) · – = no price found

Grey prices are not used for the cheapest-price ranges. Fees for blood draw or doctor's order are shown per provider. Prices in local currency converted to € at ECB rates (14 Oct 2026). How we collect prices →

How much does an ApoB test cost in the US?

Cheapest US online: $28 from Life Extension, no doctor's visit required. Blood drawn at Quest or Labcorp near you. Most sellers don't serve NY, NJ or RI. Prices by state →

What does an ApoB test measure?

ApoB is a protein on the surface of LDL, VLDL, IDL and Lp(a) particles – the lipoproteins that can carry cholesterol into artery walls. Each of these particles carries exactly one ApoB molecule, so your ApoB level is effectively a count of them.

A standard cholesterol test measures how much cholesterol those particles carry. ApoB measures how many particles there are. The two usually move together, but not always: some people have an ordinary LDL cholesterol result but a higher number of smaller particles.

This article explains a blood marker in general terms. It isn't medical advice and can't tell you what your own result means. If you have a result, a family history of early heart disease, or symptoms, talk to your doctor.

ApoB in one sentence

ApoB – short for apolipoprotein B – is a structural protein wrapped around the particles that carry cholesterol and fats through your blood, and because there's exactly one ApoB molecule per particle, measuring ApoB tells you how many of those particles you have.

Which particles carry ApoB?

Cholesterol and triglycerides don't dissolve in blood, so they travel inside particles called lipoproteins. The ones that can lodge in artery walls and contribute to plaque – LDL, VLDL, IDL and Lp(a) – each carry one ApoB-100 molecule. As a 2021 review in Metabolites puts it, this "one apoB per particle ratio makes plasma apoB concentration a direct measure of the number of circulating atherogenic lipoproteins" (Behbodikhah et al.). HDL – often called "good cholesterol" – doesn't carry ApoB.

ApoB vs LDL cholesterol: why they can disagree

A standard cholesterol test reports LDL cholesterol (LDL-C): the amount of cholesterol inside LDL particles. ApoB reports the number of particles. Most of the time the two move together. But particles vary in size and in how much cholesterol each carries. Someone with many small, cholesterol-poor particles can have an unremarkable LDL-C and a high ApoB; the reverse is also possible. This is called discordance.

The reason it matters is the proposed mechanism: it's the particles themselves that enter the artery wall. More particles means more chances for that to happen, regardless of how much cholesterol each one carries. The Metabolites review concludes there is "strong evidence that apoB is a more accurate indicator of cardiovascular risk" than total or LDL cholesterol – while also noting that ApoB measurement costs more and that replacing LDL-C with ApoB in prevention guidelines isn't yet justified. That balance is worth keeping in mind when you see ApoB described online as the only number that matters.

Discordance is more common in some groups – people with high triglycerides, type 2 diabetes, obesity or metabolic syndrome – which is exactly where guidelines single ApoB out.

What the European guidelines say

The main European reference is the 2019 ESC/EAS guideline on dyslipidaemias, updated in a 2025 focused update. On ApoB, the 2019 guideline:

• recommends ApoB analysis for cardiovascular risk assessment, particularly in people with high triglycerides, diabetes, obesity or metabolic syndrome, or very low LDL-C;
• says ApoB can be used as an alternative to LDL-C, where available, as the primary measurement for screening, diagnosis and management.

On the closely related Lp(a), the 2025 focused update confirms that Lp(a) should be measured at least once in every adult's lifetime, ideally with the first lipid profile, and treats levels above 50 mg/dL (105 nmol/L) as a risk-enhancing factor (summary). See our Lp(a) guide for more.

Guidelines tie any target to a person's overall cardiovascular risk – age, blood pressure, smoking, diabetes, family history and more. That's why a single "good" ApoB number for everyone doesn't exist, and why results belong in a conversation with a doctor.

Why longevity-focused people care about it

Cardiovascular disease remains a leading cause of death in Europe, and plaque builds up over decades. People interested in long-term health are drawn to ApoB because:

• it's a single number that reflects particle burden, which is thought to drive plaque formation;
• it can flag risk that a "normal" LDL-C might miss, especially when triglycerides are high;
• it doesn't need fasting and is a standard, automated lab test.

What it doesn't do: diagnose heart disease, show existing plaque, or replace a full risk assessment. A high result is a reason for a conversation with your doctor, not for self-treatment.

How the test works

• Sample: a standard blood sample – venous, or finger-prick where the provider offers it.
• Fasting: usually not required for ApoB alone. Follow the provider's instructions if it's part of a bigger panel.
• Units: usually g/L in Europe, mg/dL in the US.
• Timing: lipid levels take several weeks to reflect changes in diet, activity or medication, so re-testing too soon mostly measures noise.

Questions to ask your doctor

• Given my overall risk, is ApoB (or Lp(a)) worth measuring for me?
• How does my ApoB compare with my LDL cholesterol – do they agree?
• If a result is high, what would change, and when should it be re-checked?

For fasting, what affects the result and how ApoB fits with other markers, see our ApoB biomarker guide.

Who should get an ApoB test?

Research over several decades links a higher number of ApoB-containing particles with more build-up of plaque in the arteries over time. European cardiology guidelines (ESC/EAS) describe ApoB as a useful additional measure alongside LDL cholesterol, particularly for people with high triglycerides, diabetes or excess weight.

For longevity-focused testing, ApoB is popular because it is a single, direct number that can be tracked over years. It is still one piece of a bigger picture: your doctor will consider it together with blood pressure, smoking, family history and your other results.

A result is a measurement, not a diagnosis. Your doctor can usually order it under public healthcare. ApoB biomarker guide →

Sources

• Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target (Behbodikhah J et al.), Metabolites 11(10):690, 2021
• 2019 ESC/EAS Guidelines for the management of dyslipidaemias (Mach F et al.), European Heart Journal 41:111–188, 2020
• 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias